Cargando…
THU233 Reduction Of Overutilization Of 1,25-Dihydroxyvitamin D
Disclosure: J. Brown: None. M. Dewan: None. J. Courter: None. A. Spooner: None. J. Treasure: None. K. Kaplan: None. N.A. Crimmins: None. Unnecessary testing may lead to patient harm, inappropriate treatments, and/or increased cost. Per the Endocrine Society, in conjunction with Choosing Wisely, 1,25...
Autores principales: | Brown, Jeremy, Dewan, Maya, Courter, Joshua, Spooner, Andrew, Treasure, Jennifer, Kaplan, Kyle, Crimmins, Nancy Abigail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554418/ http://dx.doi.org/10.1210/jendso/bvad114.1482 |
Ejemplares similares
-
THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
por: Yazdi, Zhinoosossadat Shahidzadeh, et al.
Publicado: (2023) -
Gender-Dependent Characteristics of Serum 1,25-Dihydroxyvitamin D/25-Hydroxyvitamin D Ratio for the Assessment of Bone Metabolism
por: Fujita-Yamashita, Manami, et al.
Publicado: (2021) -
THU239 Tolvaptan For SIADH Management In Children
por: Igarashi, Mizuho, et al.
Publicado: (2023) -
THU230 Consumptive Hypothyroidism Secondary To Hemangioma
por: Thirunagari, Rajeev, et al.
Publicado: (2023) -
THU219 Vascular Damage After Craniopharyngioma
por: Beckhaus, Julia, et al.
Publicado: (2023)